Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
64,028.75 +300.90 (+0.47%) CMC Crypto 200
1,331.36 +54.38 (+4.26%)
Wilmar International Limited (WLMIF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 09:38AM EDT
| Previous close | 2.4000 |
| Open | 2.3100 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 2.3100 - 2.3100 |
| 52-week range | 2.3000 - 3.0400 |
| Volume | |
| Avg. volume | 4,675 |
| Market cap | 14.894B |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | 9.62 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.13 (5.41%) |
| Ex-dividend date | 29 Apr 2024 |
| 1y target est | N/A |
- PR Newswire
Cerecin forges strategic partnership with A*STAR's Institute of Molecular and Cell Biology (IMCB) in Singapore to advance R&D in neurological disorders.
Cerecin Inc., a clinical-stage biotechnology company at the forefront of developing innovative neurotherapeutics, is pleased to announce the establishment of a Memorandum of Understanding (MOU) with A*STAR's Institute of Molecular and Cell Biology (IMCB). This collaboration aims to accelerate research and treatment initiatives for neurological disorders and diseases to enhance overall health and brain function.
© 2024 Yahoo. All rights reserved.